Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGIOS PHARMACEUTICALS, INC. Director's Dealing 2020

Feb 19, 2020

31580_dirs_2020-02-19_e1317352-edab-497e-aab3-f736a7edbccb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2020-02-14

Reporting Person: Alenson Carman (Principal Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-16 Common stock M 790 Acquired 974 Direct
2020-02-16 Common stock M 2800 Acquired 3774 Direct
2020-02-18 Common stock F 1163 $52.01 Disposed 2611 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-14 Restricted stock units $ A 2666 Acquired Common stock (2666.0) Direct
2020-02-14 Restricted stock unit $ A 4800 Acquired Common stock (4800.0) Direct
2020-02-14 Stock option (right to buy) $51.51 A 5332 Acquired 2030-02-14 Common stock (5332.0) Direct
2020-02-16 Restricted stock units $ M 790 Disposed Common stock (790.0) Direct
2020-02-16 Restricted stock units $ M 2800 Disposed Common stock (2800.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2: The restricted stock units were granted on February 14, 2020. Beginning on February, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.

F3: The restricted stock units were granted on February 14, 2020. The shares underlying the restricted stock units will vest in full on February 14, 2022.

F4: This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.

F5: The restricted stock units were granted on February 16, 2018. The shares underlying the restricted stock units will vest in three equal annual installments on February 16, 2019, 2020 and 2021. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F6: All of the restricted stock units will vest on February 16, 2020. Vested shares will be delivered to the reporting person within three business days after such shares become vested.